ACOTEC Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Interim Results and Consider Dividend

Bulletin Express
Aug 19

Acotec Scientific Holdings Limited (ACOTEC) has announced that its board of directors will convene on 31 August 2026. The meeting’s agenda includes approval of the unaudited interim results for the six months ended 30 June 2026 and deliberation on a potential interim dividend.

The board currently comprises one executive director, Jing Li—who also serves as chairperson and chief executive officer—three non-executive directors, Silvio Rudolf Schaffner, Arthur Crosswell Butcher and June Chang, and three independent non-executive directors, Dr. Yuqi Wang, Hong Ni and Kin Yee Poon.

The notice was issued in Hong Kong on 19 August 2026. Any resolutions on interim results publication or dividend distribution will be disclosed following the board’s decision.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10